RecallDepth
Class II Ongoing

Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30

This recall is currently active, issued March 27, 2019. It was issued by Rising Pharmaceuticals, Inc..

Company
Rising Pharmaceuticals, Inc.
Recall Initiated
March 7, 2019
Posted
March 27, 2019
Recall Number
D-1052-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
30,530 bottles
Firm Location
Saddle Brook, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products

Distribution

Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.

Lot / Code Info

470170038A, exp. date 10/31/2019 470180010A, exp. date 02/29/2019 470180012A, exp. date 03/31/2020

More recalls by Rising Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls